Citadel Advisors’s Otonomy, Inc. OTIC Stock Holding History

Citadel Advisors’s Portfolio OTIC Stock Details OTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-26,400	Closed	-$59K	–	15050
2021 Q2	$59K	Sell	26,400 -27,200	-51%	-$62.8K	﹤0.01%	13268
2021 Q1	$137K	Buy	53,600 +35,700	+199%	+$146K	﹤0.01%	12156
2020 Q4	$116K	Buy	+17,900	New	+$81.3K	﹤0.01%	10132
2017 Q4	–	Sell	-45,800	Closed	-$149K	–	8595
2017 Q3	$149K	Buy	+45,800	New	+$617K	﹤0.01%	6863

Other funds holding OTIC

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

NFSG

Newbridge Financial Services Group Boca Raton, Florida $608M AUM 31.28% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Citadel Advisors's OTIC Position: Q3 2022 in Review

Citadel Advisors sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 36,160 shares — an estimated $31.7K sold.

Citadel Advisors first reported a position in OTIC in Q2 2015 and held it in 25 quarters. The position peaked at $7.81M in Q4 2020. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

Citadel Advisors reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
Citadel Advisors sold 36,160 Otonomy, Inc. shares in Q3 2022, an estimated $31.7K.
Citadel Advisors first reported a position in Otonomy, Inc. in Q2 2015 and held it in 25 quarters.
Citadel Advisors's Otonomy, Inc. position peaked at $7.81M in Q4 2020.
40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.